MX2013000433A - Sintesis de ciclopentaquinazolinas. - Google Patents

Sintesis de ciclopentaquinazolinas.

Info

Publication number
MX2013000433A
MX2013000433A MX2013000433A MX2013000433A MX2013000433A MX 2013000433 A MX2013000433 A MX 2013000433A MX 2013000433 A MX2013000433 A MX 2013000433A MX 2013000433 A MX2013000433 A MX 2013000433A MX 2013000433 A MX2013000433 A MX 2013000433A
Authority
MX
Mexico
Prior art keywords
synthesis
cyclopentaquinazolines
amino
onx
quinazolines
Prior art date
Application number
MX2013000433A
Other languages
English (en)
Inventor
Alexander James Bridges
Andrew S Thompson
Olivier DAPREMONT
James Alan Kerschen
Sean Mark Dalziel
Hyunjung Kim
James Robert Zeller
Original Assignee
Onyx Therapeuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Therapeuticals Inc filed Critical Onyx Therapeuticals Inc
Publication of MX2013000433A publication Critical patent/MX2013000433A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporciona un método de producir 6-amino-ciclopenta[g]quinazol inas, en forma enantioméricamente enriquecida. En particular el método se puede aplicar a la síntesis de ácido N-{N-{4-[N-((6S)-2-hidroximetil-4-oxo-3,4,7,8-tetrahidro-6H-ciclo -penta[g]quinazolin-6-il)-N-(prop-2-inil)amino]benzoil}-L-Y-gluta mil}-]D-glutámico (ONX-0801).
MX2013000433A 2010-07-19 2011-07-15 Sintesis de ciclopentaquinazolinas. MX2013000433A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39986110P 2010-07-19 2010-07-19
PCT/US2011/001235 WO2012011939A2 (en) 2010-07-19 2011-07-15 Synthesis of cyclopentaquinazolines

Publications (1)

Publication Number Publication Date
MX2013000433A true MX2013000433A (es) 2013-05-28

Family

ID=45497340

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000433A MX2013000433A (es) 2010-07-19 2011-07-15 Sintesis de ciclopentaquinazolinas.

Country Status (13)

Country Link
US (1) US8809526B2 (es)
EP (1) EP2595966B1 (es)
KR (1) KR20130056887A (es)
CN (1) CN103517897A (es)
AU (1) AU2011280235A1 (es)
BR (1) BR112013001350A2 (es)
CA (1) CA2804889A1 (es)
CO (1) CO6650369A2 (es)
EA (1) EA201291302A1 (es)
IL (1) IL223926A0 (es)
MX (1) MX2013000433A (es)
SG (1) SG187011A1 (es)
WO (1) WO2012011939A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105237416A (zh) * 2015-10-14 2016-01-13 湖南华腾制药有限公司 一种5-氨基茚酮的合成方法
US10611705B2 (en) 2017-05-03 2020-04-07 Exxonmobil Chemical Patents Inc. Process for conversion of acyclic C5 compounds to cyclic C5 compounds and formulated catalyst compositions used therein
WO2018204036A1 (en) * 2017-05-03 2018-11-08 Exxonmobil Chemical Patents Inc. Process for conversion of acyclic c5 compounds to cyclic c5 compounds and formulated catalyst compositions used therein
GB201707864D0 (en) 2017-05-16 2017-06-28 Inst Of Cancer Research: Royal Cancer Hospital Platinum-reistant cancer treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2272217B (en) 1992-11-06 1996-07-31 Zeneca Ltd Anti-cancer cyclopentaquinazoline tricyclic derivatives
GB9223352D0 (en) 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
PT1421105E (pt) 2001-08-31 2010-12-07 Btg Int Ltd Compostos anticancerígenos de ciclopenta-g quinazolina
WO2003020300A1 (en) 2001-08-31 2003-03-13 Btg International Limited Use of cyclopenta[g]quinazoline derivatives for treating cancer
GB0121214D0 (en) * 2001-08-31 2001-10-24 Btg Int Ltd Synthetic method
US7250611B2 (en) 2003-12-02 2007-07-31 3M Innovative Properties Company LED curing apparatus and method
WO2005084205A2 (en) * 2004-02-27 2005-09-15 Teva Pharmaceutical Industries, Ltd. Diamino thiazoloindan derivatives and their use
WO2007136875A2 (en) * 2006-05-18 2007-11-29 Arena Pharmaceuticals, Inc. Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto

Also Published As

Publication number Publication date
US8809526B2 (en) 2014-08-19
AU2011280235A1 (en) 2013-03-07
EP2595966A2 (en) 2013-05-29
CO6650369A2 (es) 2013-04-15
CA2804889A1 (en) 2012-01-26
EP2595966A4 (en) 2015-12-09
US20130211082A1 (en) 2013-08-15
WO2012011939A3 (en) 2014-04-03
EP2595966B1 (en) 2020-10-28
WO2012011939A2 (en) 2012-01-26
SG187011A1 (en) 2013-02-28
IL223926A0 (en) 2013-03-05
CN103517897A (zh) 2014-01-15
BR112013001350A2 (pt) 2016-05-17
EA201291302A1 (ru) 2013-09-30
KR20130056887A (ko) 2013-05-30

Similar Documents

Publication Publication Date Title
TN2009000296A1 (en) New process
UA102518C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
NZ610378A (en) Lipoyl compounds and their use for treating ischemic injury
MX2013000433A (es) Sintesis de ciclopentaquinazolinas.
MX2010003213A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
PH12015501266B1 (en) Crystalline diacylhydrazine and the use thereof
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
EA201390635A1 (ru) Эффективные реакции пептидного сочетания и их применение для получения и выделения тринатриевой соли циклопента[g]хиназолина
PL2101878T3 (pl) Kompozycja prostująca włosy
MX2010003184A (es) Nuevo procedimiento de sinstesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MY147697A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
UA102091C2 (ru) Способ получения сульфонилпиролов как ингибиторов hdac
JO3189B1 (ar) طريقة جديدة لتخليق (e2) -3- (3, 4- داي ميثوكسي فينيل)بروب-2 - يننيتريل واستخدامها لتخليق ايفابرادين والاملاح المضافة منها مع حمض مقبول صيدلانيا
SG195161A1 (en) Method for producing proline compound
BR112013031080A2 (pt) processo para preparar uma alquil diamina, processo para preparar 2-metil-1,2-diaminopropano e composição
UA93269C2 (en) Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant, anxyolytic), neuroprotective, heroprotective and cerebroprotective action
UA90357C2 (ru) Применение производных 2-оксоиндолин-3-глиоксиловой кислоты как средств ноотропной действия

Legal Events

Date Code Title Description
FA Abandonment or withdrawal